Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint blockade in HIV
Céline Gubser, Chris Chiu, Sharon R. Lewin, et al.
EBioMedicine (2022) Vol. 76, pp. 103840-103840
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Immune checkpoint blockade in experimental bacterial infections
Nicole Lind Henriksen, Peter Østrup Jensen, Louise Kruse Jensen
Journal of Infection (2025), pp. 106391-106391
Open Access | Times Cited: 1
Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
Chris Chiu, Maya D. Schou, James McMahon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Christoph Hieber, Stephan Grabbe, Matthias Bros
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1085-1085
Open Access | Times Cited: 12
Modelling HIV-1 control and remission
Bharadwaj Vemparala, Shreya Chowdhury, Jérémie Guedj, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
The Nexus between Leishmania & HIV: Debilitating Host Immunity and Hastening Comorbid Disease Burden
Manasvi Dhulipalla, Garima Chouhan
Experimental Parasitology (2024) Vol. 265, pp. 108826-108826
Closed Access | Times Cited: 4
Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data
Bharadwaj Vemparala, Vincent Madelain, Caroline Passaes, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 9, pp. e1012434-e1012434
Open Access | Times Cited: 4
Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure
Tess E. Peterson, Virginia S. Hahn, Ruin Moaddel, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11
Ling Li, Manzhi Zhao, Marjan van Meurs, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Healthcare provider perspectives on integrating HIV care into cancer centers in Malawi, South Africa, Uganda, and Zimbabwe
Michalina A. Montaño, Alfred Jatho, Cecilia Nassolo, et al.
Translational Oncology (2025) Vol. 53, pp. 102273-102273
Closed Access
Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+ T cells
Sina Rüeger, Eva Gruener, Danni Wang, et al.
JCI Insight (2025) Vol. 10, Iss. 7
Open Access
Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV
José M. Benito, Clara Restrepo, Jesús García‐Foncillas, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Spatial technologies to evaluate the HIV-1 reservoir and its microenvironment in the lymph node
Fatima Zaman, Melissa Smith, Ashwin Balagopal, et al.
mBio (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 3
Vaccinal effect of HIV-1 antibody therapy: dream or reality?
Mar Naranjo‐Gómez, Mireia Pelegrín
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 209-216
Closed Access | Times Cited: 9
Anti-PD-L1 antibody ASC22 in combination with a histone deacetylase inhibitor chidamide as a “shock and kill” strategy for ART-free virological control: a phase II single-arm study
Luling Wu, Zhihang Zheng, Jingna Xun, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
The impact of sex on HIV immunopathogenesis and therapeutic interventions
Erin Mihealsick, Anna Word, Eileen P. Scully
Journal of Clinical Investigation (2024) Vol. 134, Iss. 18
Open Access | Times Cited: 2
Immune Checkpoint Inhibitors and Infection: What Is the Interplay?
M Papadakis, Ioannis Karniadakis, Nikolaos Mazonakis, et al.
In Vivo (2023) Vol. 37, Iss. 6, pp. 2409-2420
Open Access | Times Cited: 5
Correlates of Sexual Lifestyles Among Older Adults Living With HIV in China: Findings From the Sexual Well-being (SWELL) Study
Bingyi Wang, Xin Peng, Leiwen Fu, et al.
Infectious Microbes & Diseases (2023)
Open Access | Times Cited: 4
Clinical trials aimed at HIV cure or remission: new pathways and lessons learned
Maya Dyveke Schou, Ole S. Søgaard, Thomas A. Rasmussen
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 11, pp. 1227-1243
Closed Access | Times Cited: 4
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2
Skye Opsteen, Tim Fram, Jacob K. Files, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2024) Vol. 96, Iss. 1, pp. 92-100
Open Access | Times Cited: 1
Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy
Robyn-Brooke Labuschagne Naidoo, Helen C. Steel, Annette J. Theron, et al.
Pathogens (2024) Vol. 13, Iss. 7, pp. 540-540
Open Access | Times Cited: 1
GITR activation ex vivo impairs CD8 T cell function in people with HIV on antiretroviral therapy
Céline Gubser, Rachel D. Pascoe, Judy Chang, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108165-108165
Open Access | Times Cited: 3
FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
Alexis Yero, Tao Shi, Jean‐Pierre Routy, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models
Aude Boulay, Sara Trabanelli, Stéphanie Boireau, et al.
ImmunoHorizons (2023) Vol. 7, Iss. 3, pp. 243-255
Open Access | Times Cited: 2
Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1
Grant Klug, Frances M. Cole, Mark D. Hicar, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 829-829
Open Access | Times Cited: 2
Recent advances in CD8+ T cell-based immune therapies for HIV cure
Valentina Restrepo Arenas, Marı́a Teresa Rugeles, Federico Perdomo-Celis, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17481-e17481
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top